| [1] |
Jurewicz A, Selmaj K. Relapse of neuromyelitis optica during pregnancy-treatment options and literature review [J]. Clin Neurol Neurosurg, 2015, 130: 159-161
|
| [2] |
Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica [J]. Lancet Neurol, 2007, 6(9): 805-815.
|
| [3] |
Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders [J]. Neurology, 2015, 14, 85(2): 177-189.
|
| [4] |
Cutolo M, Brizzolara R, Atzeni F, et al. The immunomodulatory effects of estrogens: clinical relevance in immune-mediated rheumatic diseases [J]. Ann N Y Acad Sci, 2010, 1193: 36-42.
|
| [5] |
Saito S, Sakai M, Sasaki Y, et al. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1: Th2 cell ratio during normal human pregnancy and preeclampsia [J]. Clin Exp Immunol, 1999, 117(3): 550-555.
|
| [6] |
Davoudi V, Keyhanian K, Bove RM, et al. Immunology of neuromyelitis optica during pregnancy [J]. Neurol Neuroimmunol Neuroinflamm, 2016, 3(6): e288.
|
| [7] |
Bourre B, Marignier R, Zephir H, et al. Neuromyelitis optica and pregnancy [J]. Neurology, 2012, 78(12): 875-879.
|
| [8] |
Kim W, Kim SH, Nakashima I, et al. Influence of pregnancy on neuromyelitis optica spectrum disorder [J]. Neurology, 2012, 78(16): 1264-1267.
|
| [9] |
Fragoso YD, Adoni T, Bichuetti DB, et al. Neuromyelitis optica and pregnancy [J]. J Neurol,2013, 260(10): 2614-2619.
|
| [10] |
Nour MM, Nakashima I, Coutinho E, et al. Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder [J]. Neurology, 2016, 86(1): 79-87.
|
| [11] |
Chan WF, Gurnot C, Montine TJ, et al. Male microchimerism in the human female brain [J]. PLoS One, 2012, 7(9): e45592.
|
| [12] |
Tan XW, Liao H, Sun L, et al. Fetal microchimerism in the maternal mouse brain: a novel population of fetal progenitor or stem cells able to cross the blood-brain barrier [J]? Stem Cells, 2005, 23(10): 1443-1452.
|
| [13] |
Hedlund E, Hefferan MP, Marsala M, et al. Cell therapy and stem cells in animal models of motor neuron disorders [J]. Eur J Neurosci, 2007, 26(7): p. 1721-1737.
|
| [14] |
Ferguson TA and Elman LB. Clinical presentation and diagnosis of amyotrophic lateral sclerosis [J]. NeuroRehabilitation, 2007, 22(6): 409-416.
|
| [15] |
Kenner M, Menon U and Elliott DG. Multiple sclerosis as a painful disease [J]. Int Rev Neurobiol, 2007, 79: 303-321.
|
| [16] |
Zhang G, Zhao Y, Li XM, et al. Fetal cell microchimerism in the maternal mouse spinal cord [J]. Neurosci Bull, 2014, 30(1): 81-89.
|
| [17] |
Saadoun S, Waters P, Leite MI, et al. Neuromyelitis optica IgG causes placental inflammation and fetal death [J]. J Immunol, 2013, 191(6): 2999-3005.
|
| [18] |
Gunaydin B, Akcali D, and Alkan M. Epidural anaesthesia for caesarean section in a patient with Devic′s Syndrome [J]. Anaesthesia, 2001, 56(6): 565-567.
|
| [19] |
Sinha A and Bagga A. Pulse steroid therapy [J]. Indian journal of pediatrics, 2008, 75(10): 1057-66.
|
| [20] |
Stangel M, Baumann U, Borte M, et al. Treatment of neurological autoimmune diseases with immunoglobulins: first insights from the prospective SIGNS registry [J]. J Clin Immunol, 2013, 33 Suppl 1: S67-71.
|
| [21] |
Okada K, Tsuji S and Tanaka K. Intermittent intravenous immunoglobulin successfully prevents relapses of neuromyelitis optica [J]. Intern Med, 2007, 46(19): 1671-1672.
|
| [22] |
Rubio Tabares J, Amaya Gonzalez PF. Plasma exchange therapy for severe relapse of Devic′s disease in a pregnant woman: A case report andconcise review [J]. Clin Neurol Neurosurg, 2016, 148: 88-90.
|
| [23] |
Koh JH, Ko HS, Lee J, et al. Pregnany and patients with preexisting lupus nephritis: 15 years of experience at a single center in Korea [J]. Lupus. 2015, 24(7): 764-772.
|
| [24] |
Carmichael SL, Shaw GM, Ma C, et al. Maternal corticosteroid use and orofacial clefts [J]. Am J Obstet Gynecol, 2007, 197(6): 585.e1-585.
|
| [25] |
Hosseini-Carroll P, Mutyala M, Seth A, etal. Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient management [J]. World J Gastrointest Pharmacol Ther, 2015, 6(4): 156-171.
|
| [26] |
Lannes G, Elias FR, Cunha B, et al. Successful pregnancy after cyclophosphamide therapy for lupus nephritis [J]. Arch Gynecol Obstet, 2011, 283(Suppl 1): 61-65.
|
| [27] |
Weber-Schoendorfer C, Chambers C, Wacker E, et al. Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study [J]. Arthritis Rheumatol, 2014, 66(5): 1101-1110.
|
| [28] |
Cassina M, Johnson DL, Robinson LK, et al. Pregnancy outcome in women exposed to leflunomide before or during pregnancy [J]. Arthritis Rheum, 2012, 64(7): 2085-2094.
|
| [29] |
Friedrichs B, Tiemann M, Salwender H, et al. The effects of rituximab treatment during pregnancy on a neonate [J]. Haematologica, 2006, 91(10): 1426-147.
|
| [30] |
Goldstein LH, Dolinsky G, Greenberg R, et al. Pregnancy outcome of women exposed to azathioprine during pregnancy [J]. Birth Defects Res A Clin Mol Teratol, 2007, 79(10): 696-701.
|
| [31] |
Plauborg AV, Hansen AV and Garne E. Use of azathioprine and corticosteroids during pregnancy and birth outcome in women diagnosed with inflammatory bowel disease [J]. Birth Defects Res A Clin Mol Teratol, 2016, 106(6): 494-499.
|
| [32] |
Ponticelli C and Moroni G. Immunosuppression in pregnant women with systemic lupus erythematosus [J]. Expert Rev Clin Immunol, 2015, 11(5): 549-552.
|